全文获取类型
收费全文 | 2319篇 |
免费 | 169篇 |
国内免费 | 65篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 109篇 |
妇产科学 | 19篇 |
基础医学 | 124篇 |
口腔科学 | 86篇 |
临床医学 | 267篇 |
内科学 | 172篇 |
皮肤病学 | 197篇 |
神经病学 | 88篇 |
特种医学 | 234篇 |
外国民族医学 | 1篇 |
外科学 | 406篇 |
综合类 | 424篇 |
预防医学 | 28篇 |
眼科学 | 130篇 |
药学 | 87篇 |
1篇 | |
中国医学 | 10篇 |
肿瘤学 | 104篇 |
出版年
2024年 | 2篇 |
2023年 | 38篇 |
2022年 | 50篇 |
2021年 | 69篇 |
2020年 | 98篇 |
2019年 | 71篇 |
2018年 | 61篇 |
2017年 | 60篇 |
2016年 | 73篇 |
2015年 | 65篇 |
2014年 | 165篇 |
2013年 | 152篇 |
2012年 | 127篇 |
2011年 | 135篇 |
2010年 | 128篇 |
2009年 | 121篇 |
2008年 | 108篇 |
2007年 | 123篇 |
2006年 | 141篇 |
2005年 | 120篇 |
2004年 | 103篇 |
2003年 | 72篇 |
2002年 | 66篇 |
2001年 | 51篇 |
2000年 | 56篇 |
1999年 | 36篇 |
1998年 | 27篇 |
1997年 | 29篇 |
1996年 | 24篇 |
1995年 | 21篇 |
1994年 | 19篇 |
1993年 | 17篇 |
1992年 | 8篇 |
1991年 | 9篇 |
1990年 | 11篇 |
1989年 | 12篇 |
1988年 | 14篇 |
1987年 | 6篇 |
1986年 | 9篇 |
1985年 | 10篇 |
1984年 | 11篇 |
1983年 | 14篇 |
1982年 | 4篇 |
1981年 | 6篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1976年 | 4篇 |
1973年 | 1篇 |
排序方式: 共有2553条查询结果,搜索用时 234 毫秒
1.
We describe a 3‐month‐old child with an infantile hemangioma on the forehead with a blanched macule provoked by topical treatment with propranolol. This observation demonstrates that topically applied (non‐selective) beta‐blockers may induce blanched macules at the site of application, a side effect due to peripheral vasoconstriction of blood vessels by non‐selective beta‐2 blockade. This side effect was linked due to overuse and was reversible. This case illustrates the importance of providing thorough instructions regarding topical propranolol application. 相似文献
2.
3.
Sabrina P Koh Philip Leadbitter Fiona Smithers 《Expert review of clinical pharmacology》2020,13(8):899-915
ABSTRACT
Introduction
Fifteen percent of proliferating infantile hemangioma (IH) require intervention because of the threat to function or life, ulceration, or tissue distortion. Propranolol is the mainstay treatment for problematic proliferating IH. Other β-blockers and angiotensin-converting enzyme (ACE) inhibitors have been explored as alternative treatments. 相似文献4.
目的探讨不同时期婴幼儿口腔颌面部血管瘤TRAIL受体DR4、DR5 m RNA的表达及意义。方法本研究于2013年3—10月在中国医科大学中心实验室完成。收集婴幼儿口腔颌面部血管瘤组织标本40例(增殖期血管瘤26例、退化期血管瘤14例),以及正常皮肤组织标本12例,应用RT-PCR检测TRAIL的2个受体DR4和DR5m RNA在其中的分布情况。结果增殖期血管瘤组织中DR4和DR5 m RNA的表达强度显著低于退化期血管瘤和正常皮肤组织,差异有统计学意义(P<0.01)。退化期血管瘤和正常皮肤组织中DR4、DR5 m RNA的表达强度较高,但二者之间差异无统计学意义。结论退化期血管瘤组织DR4和DR5 m RNA表达程度高,与增殖期血管瘤相比,退化期血管瘤可以更多的结合TRAIL,细胞凋亡增多,引发血管瘤消退。 相似文献
5.
Fleur Cordier Anne Hoorens Jo Van Dorpe David Creytens 《World journal of hepatology》2021,13(10):1316-1327
Differential diagnosis of pediatric vascular liver tumors can be challenging due to inconsistent nomenclature, histologic overlap and the rarity of some entities. Here we give an up-to-date overview of the most important entities. We discuss the clinic, histology and pathophysiology of hepatic congenital and infantile heman-gioma, hepatic epithelioid hemangioendothelioma and hepatic angio-sarcoma. 相似文献
6.
目的:采用网状Meta分析方法,将普萘洛尔联合其他治疗与各对照治疗措施进行对比。方法:以“普萘洛尔”,“血管瘤”为关键词检索CNKI、VIP、万方数据;以“propranolol”“hemangioma”为关键词检索Cochrane Library、Embase、pubmed。检索期限为建库至2019年6月1日。采用STATA14.0软件Network程序包进行数据分析。结果:共纳入18篇文献,涉及8项治疗措施,共纳入1469例血管瘤患者。网状Meta分析结果显示:4种联合治疗方式与单纯口服普萘洛尔相比疗效均优于单纯口服普萘洛尔治疗。普萘洛尔联合注射平阳霉素、普萘洛尔联合外用噻吗洛尔、普萘洛尔联合敷贴器的有效率均优于对应的注射平阳霉素、外用噻吗洛尔及敷贴器。各治疗措施的有效性排序为:普萘洛尔联合敷贴器>普萘洛尔联合外用噻吗洛尔>普萘洛尔联合口服糖皮质激素>普萘洛尔联合注射平阳霉素>敷贴器照射>外用噻吗洛尔>口服普萘洛尔>注射平阳霉素。结论:对于婴幼儿血管瘤的治疗,普萘洛尔联合治疗措施疗效均优于单纯的口服普萘洛尔治疗,其中普萘洛尔联合敷贴器的疗效最佳。 相似文献
7.
Peng-Fei Lin Fa-Chun Chen Jia-Yao Chen Cheng-Hong Jiang 《The Journal of dermatology》2020,47(10):1119-1125
Infantile hemangiomas (IH) are at risk of incomplete regression with remnant permanent sequelae, ranging from passive waiting for spontaneous regression to active systemic administration. The application of traditional therapy involving injection of a sclerosing agent is limited due to the difficulty in achieving cosmetic improvement. This study aimed to explore a new injection method that could not only promote tumor regression but also achieve cosmetic improvement. A total of 122 IH (from 109 children) injected intralesionally with lauromacrogol in the Plastic Surgery Department of Fujian Medical University Union Hospital between 1 January 2012 and 1 June 2019 were enrolled in this study. The mean follow-up time was 2.9 years. Of 122 lesions studied, 111 (91.0%) achieved complete regression, 10 (8.2%) achieved significant regression and one (0.8%) achieved moderate regression. In terms of aesthetic appearance, 70 (57.4%) IH had no sequelae and the A score was 5/5. Twenty-one (17.2%) IH had minimal hyperpigmentation, hypopigmentation or telangiectasia and the A score was 4/5. Thirty-one (25.4%) IH had left mild or relatively obvious sequelae and the A score was 1–3/5. None of the 122 IH involved had rebound growth after terminating the treatment. Hyper- or hypopigmentation gradually faded over time and part of the IH had already returned to normal appearance by the time of long-term follow up. The results indicated that this new type of injection therapy significantly promoted the regression of uncomplicated IH and helped achieve the expected cosmetic appearance. 相似文献
8.
《Actas dermo-sifiliográficas》2020,111(1):59-62
Propranolol, a non-selective beta-blocker, remains the first line of treatment for problematic infantile hemangioma. However, although rarely, a subset of patients experience undesirable side effects, raising interest in other selective beta-blockers. We present a large case series of 46 infants treated successfully with oral atenolol, a selective beta-1 blocker. 相似文献
9.
An anastomosing hemangioma is a relatively new diagnosis of a benign vascular lesion that is typically found in the genitourinary tract. On imaging, anastomosing hemangiomas have a broad differential diagnosis and can resemble malignant lesions such as angiosarcoma. Here we present a case of a 33-year-old male with seizures who on imaging was found to have a presumed recurrent intracranial meningioma. After surgical resection of his lesion, this case was pathologically diagnosed as having anastomosing hemangioma. To our knowledge, this is the first report of a case of a thrombosed anastomosing hemangioma located at intracranial and intradural region. 相似文献
10.
AimLncRNA MALAT1 is involved in regulation of angiogenesis, however, its expression and mechanism in infantile hemangioma (IH) are less reported. The study aimed to investigate MALAT1 in IH and to reveal the potential mechanism of MALAT1 acting on IH.MethodsIsolated form IH tissue, human CD31+ hemangioma endothelial cells (HemECs) were cultured and sorted by magnetic-activated cell sorting (MACS). Quantitative real-time (qRT)-PCR was performed to detect the expressions of MALAT1, miR-206 and VEGFA. The correlations among MALAT1, miR-206 and VEGFA were confirmed by bioinformatics analysis and dual-luciferase reporter assay. The effects of MALAT1, miR-206 and VEGFA on cell proliferation were detected by cell counting kit-8 (CCK-8) and cell colony formation assay. Flow cytometry, wound scratch, Transwell and Tube formation assay were performed to determine cell apoptosis, migration, invasion and vasoformation, respectively. Apoptosis-related proteins were determined by Western blot.ResultsThe results showed that MALAT1 and VEGFA were high-expressed and miR-206 was low-expressed in IH tissues. SiMALAT1 negatively affected the cell proliferation, migration, invasion and vasoformation of HemECs and promoted apoptosis of HemECs. Moreover, Bcl-2 expression was significantly inhibited and the expressions of Bax and c cleaved-3 were greatly promoted. MALAT1 directly targeted and inhibited the expression of miR-206, and VEGFA was predicted to be the target gene for miR-206. SiMALAT1 suppressed the cell proliferation, migration, invasion and vasoformation of HemECs through modulating miR-206/VEGFA axis.ConclusionKnock-down of MALAT1 inhibits the growth of HemECs through regulating miR-206/VEGFA axis, indicating that MALAT1 is a potential therapeutic mechanism for the treatment of IH. 相似文献